• Why we continue to like Sirtex

    Scott Shuttleworth
    October 21, 2016

    At the end of August we provided some brief comments on the FY16 results of Sirtex Medical Limited (ASX:SRX).  At the time, we noted that SRX should be on the radar of every value investor.  We continue to hold that view, and are happy to share our most recent thoughts on the variables we consider when evaluating the business.


    subscribe for free
    or sign in to access the article

    by Scott Shuttleworth Posted in Companies.